Insider Transactions in Q4 2024 at Icu Medical Inc (ICUI)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 06
2024
|
Daniel Woolson VP, GM-Infusion Capital |
SELL
Open market or private sale
|
Direct |
2,241
-17.1%
|
$349,596
$156.25 P/Share
|
|
Dec 02
2024
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
12,000
-3.51%
|
$1,956,000
$163.14 P/Share
|
|
Dec 02
2024
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+9.33%
|
$1,056,000
$88.76 P/Share
|
|
Nov 27
2024
|
David C. Greenberg Director |
SELL
Open market or private sale
|
Direct |
972
-16.18%
|
$153,576
$158.11 P/Share
|
|
Nov 27
2024
|
David C. Greenberg Director |
BUY
Exercise of conversion of derivative security
|
Direct |
972
+13.92%
|
$91,368
$94.68 P/Share
|
|
Nov 27
2024
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,430
-100.0%
|
$225,940
$158.0 P/Share
|
|
Nov 27
2024
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,430
+50.0%
|
$137,280
$96.83 P/Share
|
|
Nov 26
2024
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,719
-98.67%
|
$1,227,321
$159.59 P/Share
|
|
Nov 26
2024
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,719
+50.0%
|
$741,024
$96.83 P/Share
|
|
Nov 25
2024
|
Christian B. Voigtlander Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,962
-100.0%
|
$331,578
$169.08 P/Share
|
|
Nov 25
2024
|
Christian B. Voigtlander Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,962
+50.0%
|
$188,352
$96.83 P/Share
|
|
Nov 01
2024
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
12,000
-2.67%
|
$2,064,000
$172.26 P/Share
|
|
Nov 01
2024
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+9.33%
|
$1,056,000
$88.76 P/Share
|
|
Oct 01
2024
|
Vivek Jain Chairman and CEO |
SELL
Open market or private sale
|
Direct |
12,000
-2.67%
|
$2,136,000
$178.91 P/Share
|
|
Oct 01
2024
|
Vivek Jain Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+9.33%
|
$1,056,000
$88.76 P/Share
|